Cargando…
Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo
Ligand-mediated prostate cancer (PCa)-targeting gene delivery is one of the focuses of research in recent years. Our previous study reported the successful preparation of aptamer-modified nanoparticles (APT-NPs) in our laboratory and demonstrated their PCa-targeting ability in vitro. However, the me...
Autores principales: | Wu, Xin, Tai, Zongguang, Zhu, Quangang, Fan, Wei, Ding, Baoyue, Zhang, Wei, Zhang, Lijuan, Yao, Chong, Wang, Xiaoyu, Ding, Xueying, Li, Qin, Li, Xiaoyu, Liu, Gaolin, Liu, Jiyong, Gao, Shen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247134/ https://www.ncbi.nlm.nih.gov/pubmed/25473281 http://dx.doi.org/10.2147/IJN.S71101 |
Ejemplares similares
-
Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy
por: Wu, Xin, et al.
Publicado: (2011) -
Reduction-responsive cross-linked stearyl peptide for effective delivery of plasmid DNA
por: Yao, Chong, et al.
Publicado: (2015) -
Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity
por: Ding, Baoyue, et al.
Publicado: (2011) -
Degradable gene delivery systems based on Pluronics-modified low-molecular-weight polyethylenimine: preparation, characterization, intracellular trafficking, and cellular distribution
por: Fan, Wei, et al.
Publicado: (2012) -
Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer
por: Tai, Zongguang, et al.
Publicado: (2020)